Dolby Laboratories, Inc.
DLBDolby Laboratories, Inc. (Dolby Labs or simply Dolby) is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers. Dolby is best known for their audio encoding format, Dolby Digital, which popularized the use of surround sound in media.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
20dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How DLB's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Dolby Laboratories, Inc.'s next FDA catalyst?→
Dolby Laboratories, Inc.'s (DLB) next tracked catalyst is a Earnings expected July 30, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track DLB biotech catalysts?→
Add DLB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Dolby Laboratories, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.